Mitochondrial Dysfunction as a Molecular Target for Novel Therapeutic Strategies in Human Disease Treatment

Abstract

Mitochondria are essential cellular organelles responsible for energy production, metabolic regulation, calcium homeostasis, and control of programmed cell death. Beyond their traditional role as energy-generating structures, mitochondria function as complex signalling platforms that regulate multiple physiological and pathological processes. Disruption of mitochondrial structure and function, commonly referred to as mitochondrial dysfunction, has been increasingly recognized as a critical contributor to the development and progression of various human diseases, including cancer, neurodegenerative disorders, cardiovascular diseases, metabolic syndromes, and inflammatory conditions.

Mitochondrial dysfunction is characterized by impaired oxidative phosphorylation, excessive production of reactive oxygen species, altered mitochondrial dynamics, defective quality control mechanisms, and disturbances in cellular metabolism. These abnormalities can promote cellular damage, inflammation, impaired energy balance, and disease progression. As a result, mitochondria have emerged as promising molecular targets for developing novel therapeutic strategies aimed at restoring cellular function and improving disease outcomes.

This review discusses the fundamental biological functions of mitochondria and examines the molecular mechanisms involved in mitochondrial dysfunction. It further explores emerging pharmacological approaches targeting mitochondrial pathways, including antioxidant therapies, mitochondrial biogenesis regulators, metabolic modulators, mitochondrial quality control enhancers, and targeted drug delivery strategies. The therapeutic potential of mitochondrial interventions in cancer, neurological disorders, cardiovascular diseases, and metabolic conditions is also evaluated.

Although mitochondrial-targeted therapies have demonstrated considerable promise, several challenges remain, including tissue-specific effects, drug delivery limitations, and the complexity of mitochondrial regulation. Advances in molecular pharmacology, nanotechnology, and precision medicine are expected to improve the development of mitochondria-focused therapeutic approaches. Understanding mitochondrial biology and its role in disease mechanisms may provide new opportunities for designing effective treatments and improving clinical outcomes.